Diagnosis and Treatment of Complicated Pleural Effusion

Complicated Pleural Effusion의 진단과 치료

  • Kim, Seok-Chan (Department of Pulmonology, The Catholic University of Korea School of Medicine)
  • 김석찬 (가톨릭대학교 의과대학 호흡기내과)
  • Published : 2011.08.01

Abstract

Parapneumonic effusion is pleural effusion that arises in the pleural space, complicated with bacterial pneumonia. This occurs in at least forty percent of bacterial pneumonia. The usual parapneumonic effusion resolves well with antibiotic therapy. However, if bacteria invade the pleural space, a complicated parapneumonic effusion or empyema may result. In addition to appropriate antibiotic therapy, some parapneumonic effusions and empyemas need additional treatment, such as drainage procedures. The necessity of drainage for treatment of parapneumonic effusions depends on the several types or stages of parapneumonic effusion. Empyemas may need additional intervention beyond simple chest tube drainage, including placement of additional drainage tubes under fluoroscopy, video-assisted thoracoscopy with lysis of adhesions, and decortication. Patients with persistent air leaks often require surgical or endoscopic repair procedures.

Keywords

References

  1. Light RW, Girard WM, Jenkinson SG, George RB. Parapneumonic effusions. Am J Med 1980;69:507-512. https://doi.org/10.1016/0002-9343(80)90460-X
  2. Heffner JE, Klein JS, Hampson C. Diagnostic utility and clinical application of imaging for pleural space infections. Chest 2010;137:467-479. https://doi.org/10.1378/chest.08-3002
  3. Moskowitz H, Platt RT, Schachar R, Mellins H. Roentgen visualization of minute pleural effusion. An experimental study to determine the minimum amount of pleural fluid visible on a radiograph. Radiology 1973;109:33-35.
  4. Woodring JH. Recognition of pleural effusion on supine radiographs: how much fluid is required? AJR Am J Roentgenol 1984;142:59-64. https://doi.org/10.2214/ajr.142.1.59
  5. Aquino SL, Webb WR, Gushiken BJ. Pleural exudates and transudates: diagnosis with contrast-enhanced CT. Radiology 1994;192:803-808.
  6. Waite RJ, Carbonneau RJ, Balikian JP, Umali CB, Pezzella AT, Nash G. Parietal pleural changes in empyema: appearances at CT. Radiology 1990;175:145-150.
  7. Kearney SE, Davies CW, Davies RJ, Gleeson FV. Computed tomography and ultrasound in parapneumonic effusions and empyema. Clin Radiol 2000;55:542-547. https://doi.org/10.1053/crad.1999.0480
  8. Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 2000;118:1158-1171. https://doi.org/10.1378/chest.118.4.1158
  9. Heffner JE, Brown LK, Barbieri C, DeLeo JM. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am J Respir Crit Care Med 1995;151:1700-1708. https://doi.org/10.1164/ajrccm.151.6.7767510
  10. Sahn SA. State of the art. The pleura. Am Rev Respir Dis 1988;138:184-234. https://doi.org/10.1164/ajrccm/138.1.184
  11. Porcel JM, Vives M, Cao G, et al. Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J 2009;34:1383-1389. https://doi.org/10.1183/09031936.00197208
  12. Porcel JM. Pleural fluid tests to identify complicated parapneumonic effusions. Curr Opin Pulm Med 2010;16:357-361. https://doi.org/10.1097/MCP.0b013e328338a108
  13. Boyanova L, Vladimir D, Gergova G, et al. Anaerobic microbiology in 198 cases of pleural empyema: a Bulgarian study. Anaerobe 2004;10:261-267. https://doi.org/10.1016/j.anaerobe.2004.06.001
  14. Civen R, Jousimies-Somer H, Marina M, Borenstein L, Shah H, Finegold SM. A retrospective review of cases of anaerobic empyema and update of bacteriology. Clin Infect Dis 1995;20 Suppl 2:S224-S229.
  15. Brook I, Frazier EH. Aerobic and anaerobic microbiology of empyema. A retrospective review in two military hospitals. Chest 1993;103:1502-1507. https://doi.org/10.1378/chest.103.5.1502
  16. Chen KY, Hsueh PR, Liaw YS, Yang PC, Luh KT. A 10-year experience with bacteriology of acute thoracic empyema: emphasis on Klebsiella pneumoniae in patients with diabetes mellitus. Chest 2000;117:1685-1689. https://doi.org/10.1378/chest.117.6.1685
  17. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008;198:962-970. https://doi.org/10.1086/591708
  18. Luh SP, Chou MC, Wang LS, Chen JY, Tsai TP. Video-assisted thoracoscopic surgery in the treatment of complicated parapneumonic effusions or empyemas: outcome of 234 patients. Chest 2005;127:1427-1432. https://doi.org/10.1378/chest.127.4.1427
  19. Kelly JW, Morris MJ. Empyema thoracis: medical aspects of evaluation and treatment. South Med J 1994;87:1103-1110. https://doi.org/10.1097/00007611-199411000-00009
  20. Vaudaux P, Waldvogel FA. Gentamicin inactivation in purulent exudates: role of cell lysis. J Infect Dis 1980;142:586-593. https://doi.org/10.1093/infdis/142.4.586
  21. Berger HA, Morganroth ML. Immediate drainage is not required for all patients with complicated parapneumonic effusions. Chest 1990;97:731-735. https://doi.org/10.1378/chest.97.3.731
  22. Wozniak CJ, Paull DE, Moezzi JE, et al. Choice of first intervention is related to outcomes in the management of empyema. Ann Thorac Surg 2009;87:1525-1530; discussion 1530-1531. https://doi.org/10.1016/j.athoracsur.2009.01.028
  23. Maskell NA, Davies CW, Nunn AJ, et al. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005;352:865-874. https://doi.org/10.1056/NEJMoa042473
  24. Rahman NM, Maskell NA, Davies CW, et al. The relationship between chest tube size and clinical outcome in pleural infection. Chest 2010;137:536-543. https://doi.org/10.1378/chest.09-1044
  25. Roberts HS. BTS guidelines for the management of pleural infection. Thorax 2004;59:178; author reply 178. https://doi.org/10.1136/thorax.2003.013094
  26. Tokuda Y, Matsushima D, Stein GH, Miyagi S. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis. Chest 2006;129:783-790. https://doi.org/10.1378/chest.129.3.783
  27. Potaris K, Mihos P, Gakidis I, Chatziantoniou C. Video-thoracoscopic and open surgical management of thoracic empyema. Surg Infect (Larchmt) 2007;8:511-517. https://doi.org/10.1089/sur.2006.049
  28. Lardinois D, Gock M, Pezzetta E, et al. Delayed referral and gram-negative organisms increase the conversion thoracotomy rate in patients undergoing video- assisted thoracoscopic surgery for empyema. Ann Thorac Surg 2005;79:1851-1856. https://doi.org/10.1016/j.athoracsur.2004.12.031
  29. Wurnig PN, Wittmer V, Pridun NS, Hollaus PH. Video-assisted thoracic surgery for pleural empyema. Ann Thorac Surg 2006;81:309-313. https://doi.org/10.1016/j.athoracsur.2005.06.065
  30. Chan DT, Sihoe AD, Chan S, et al. Surgical treatment for empyema thoracis: is video-assisted thoracic surgery "better" than thoracotomy? Ann Thorac Surg 2007;84:225-231. https://doi.org/10.1016/j.athoracsur.2007.03.019
  31. Tong BC, Hanna J, Toloza EM, et al. Outcomes of video-assisted thoracoscopic decortication. Ann Thorac Surg 2010;89:220-225. https://doi.org/10.1016/j.athoracsur.2009.09.021
  32. Striffeler H, Gugger M, Im Hof V, Cerny A, Furrer M, Ris HB. Video-assisted thoracoscopic surgery for fibrinopurulent pleural empyema in 67 patients. Ann Thorac Surg 1998;65:319-323. https://doi.org/10.1016/S0003-4975(97)01188-0
  33. Doelken P, Huggins JT, Pastis NJ, Sahn SA. Pleural manometry: technique and clinical implications. Chest 2004;126:1764-1769. https://doi.org/10.1378/chest.126.6.1764
  34. Heidecker J, Huggins JT, Sahn SA, Doelken P. Pathophysiology of pneumothorax following ultrasound-guided thoracentesis. Chest 2006;130:1173-1184. https://doi.org/10.1378/chest.130.4.1173
  35. Tan C, Sedrakyan A, Browne J, Swift S, Treasure T. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J Cardiothorac Surg 2006;29:829-838. https://doi.org/10.1016/j.ejcts.2005.12.025
  36. Yoshida K, Sugiura T, Takifuji N, et al. Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515. Lung Cancer 2007;58:362-368. https://doi.org/10.1016/j.lungcan.2007.07.009
  37. Balassoulis G, Sichletidis L, Spyratos D, et al. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion. Am J Clin Oncol 2008;31:384-389. https://doi.org/10.1097/COC.0b013e318165c061
  38. Agarwal R, Paul AS, Aggarwal AN, Gupta D, Jindal SK. A randomized controlled trial of the efficacy of cosmetic talc compared with iodopovidone for chemical pleurodesis. Respirology 2011 May 23 [Epub]. DOI: 10.1111/j.1440-1843.2011.01999.x.
  39. Salomaa ER, Pulkki K, Helenius H. Pleurodesis with doxycycline or Corynebacterium parvum in malignant pleural effusion. Acta Oncol 1995;34:117-121. https://doi.org/10.3109/02841869509093649
  40. Terra RM, Kim SY, Pego-Fernandes PM, Teixeira LR, Vargas FS, Jatene FB. Is silver nitrate pleurodesis for patients with malignant pleural effusion feasible and safe when performed in an outpatient setting? Ann Surg Oncol 2011;18:1145-1150. https://doi.org/10.1245/s10434-010-1447-8
  41. Steger V, Mika U, Toomes H, et al. Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodeses. Ann Thorac Surg 2007;83:1940-1945. https://doi.org/10.1016/j.athoracsur.2007.02.061
  42. Sudduth CD, Sahn SA. Pleurodesis for nonmalignant pleural effusions. Recommendations. Chest 1992;102:1855-1860. https://doi.org/10.1378/chest.102.6.1855
  43. Glazer M, Berkman N, Lafair JS, Kramer MR. Successful talc slurry pleurodesis in patients with nonmalignant pleural effusion. Chest 2000;117:1404-1409. https://doi.org/10.1378/chest.117.5.1404
  44. Herrington JD, Gora-Harper ML, Salley RK. Chemical pleurodesis with doxycycline 1 g. Pharmacotherapy 1996;16:280-285.
  45. Light RW. Talc should not be used for pleurodesis. Am J Respir Crit Care Med 2000;162:2024-2026. https://doi.org/10.1164/ajrccm.162.6.pc09-00b
  46. Sahn SA. Talc should be used for pleurodesis. Am J Respir Crit Care Med 2000;162:2023-2024; discussion 2026. https://doi.org/10.1164/ajrccm.162.6.pc09-00a
  47. Schneider T, Reimer P, Storz K, et al. Recurrent pleural effusion: who benefits from a tunneled pleural catheter? Thorac Cardiovasc Surg 2009;57:42-46. https://doi.org/10.1055/s-2008-1039109
  48. Artemiou O, Marta GM, Klepetko W, Wolner E, Muller MR. Pleurovenous shunting in the treatment of nonmalignant pleural effusion. Ann Thorac Surg 2003;76:231-233. https://doi.org/10.1016/S0003-4975(03)00193-0